Almac’s Clinical Services is introducing enhanced containment equipment and processes for dispensing and bottling solid-dosage products at its EU and U.S. headquarters. The Almac Group offers services ranging from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology to commercial-scale manufacture.
Almac is expanding its commercial manufacturing, thanks to a total investment of £13.7million, which includes some financial support from Invest Northern Ireland. Expansions at its Craigavon, Northern Ireland, site include a new non-GMP drug development facility as well as the creation of a new 13,400-sq-ft formulation development facility and analytical laboratories. Over the next three years, up to 229 jobs will be created, Almac reported in a press release.
SteriPack USA, which opened its first U.S. medical packaging converting facility in Lakeland, FL, last year, has received the “Governor’s Business Ambassador Award” from Florida Governor Rick Scott.
SteriPack USA was recognized for "exceeding commitments in job creation," the company reported in a press release, and it "will seek further employment in the near future."
Frazier Healthcare reports that it has agreed to acquire AndersonBrecon, the contract pharmaceutical packaging business and wholly owned subsidiary of AmerisourceBergen Corp. Frazier Healthcare provides growth equity and venture capital to high-growth healthcare service and biopharma companies, and it will combine Packaging Coordinators Inc. (PCI) with AndersonBrecon to offer global packaging support.
|PMP News, March 1999|
Thanks to ISO 11607 and other milestones, medical device packaging has gained definite stature over the last two decades.
Aphena Pharma Solutions Inc., a contract packager, repackager, and manufacturer for the pharmaceutical, OTC, dietary supplements, animal health, health and beauty, consumer health, and medical device markets, has acquired 14 OTC products from G&W Laboratories.
The company reports in a press release that the acquisition is part of its strategy "to expand its existing and future customers' access to the growing private-label marketplace by purchasing both small- and large-scale private-label offerings."